multiple-sclerosis

Documents about multiple-sclerosis

• Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study#147503HAL (France)
• Motor and Balance Assessment in Multiple Sclerosis Using Augmented Reality: Concurrent Validation Against Laboratory Reference Measures#157969Europe PMC
• Discrepancy between subjective and objective cognitive function in multiple sclerosis and association with mood, fatigue, and pain.#193386NCBI PubMed Central
• Broadening the understanding of fatigue in multiple sclerosis: a qualitative study protocol of the EMA-FAMS project.#209487NCBI PubMed Central
• Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis#264244White Rose Research Online
• Pathological extracellular matrix changes in decellularized normal appearing gray matter and subpial multiple sclerosis lesions.#281036NCBI PubMed Central
• Exploring the relationship between retinal damage and cognition in multiple sclerosis: a cross-sectional OCT-MRI study.#288578NCBI PubMed Central
• Oligodendrocyte Piezo2 is a regulator of age-dependent myelin integrity and dysregulated in multiple sclerosis.#301644NCBI PubMed Central
• Navigating uncertainty together: a participatory mixed-method study of counseling services for couples living with multiple sclerosis.#354487NCBI PubMed Central
• Perceptions of People With Multiple Sclerosis Who Practice Tai Chi and/or Qigong: A Mixed-Methods Study.#402524NCBI PubMed Central
• Early Upper Limb Motor Impairment in Multiple Sclerosis Across EDSS Levels: A Case-Control Study.#420985NCBI PubMed Central
• Machine learning methods evaluation for identification of cognitive phenotypes in multiple sclerosis and their MRI correlates.#438870NCBI PubMed Central
• Discriminative Abilities of Macular and Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis and Optic Neuritis.#613357NCBI PubMed Central
• Developing and Testing a Comprehensive MS Spasticity Management Program#800709ClinicalTrials.gov
• Influence of Emotional Disorders and Executive on the Components Retrograde and Anterograde Episodic Memory in MS#807386ClinicalTrials.gov
• Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)#808003ClinicalTrials.gov
• High-intensity Training and Its Effects on Neuroplasticity#812732ClinicalTrials.gov
• Tele-Assessment and Face-to-Face Evaluation of Balance in MS#826601ClinicalTrials.gov
• Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction#838356ClinicalTrials.gov
• A Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis#848851ClinicalTrials.gov
• Effectiveness of the Combination Strategy of Disease-Modifying Therapy and the Yishen Daluo Yin Modified Formula for Multiple Sclerosis#856847ClinicalTrials.gov
• Development of a Telehealth Obesity Intervention for Patients With MS: Modifying Diet and Exercise in MS#861919ClinicalTrials.gov
• Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839#871523ClinicalTrials.gov
• Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease#877855ClinicalTrials.gov
• Smart Wearable Device (gaitQ): Walk Better Project#912179ClinicalTrials.gov
• Effects of Vitamin K on Redness Associated With Injection Site Reactions in Participants Treated With Plegridy#918225ClinicalTrials.gov
• Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis#905639ClinicalTrials.gov
• A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis#374715IRIS
• Clinical features of 314 patients with relapsing-remitting multiple sclerosis [Esclerosis múltiple recurrente remitente en el sector público de salud de chile. descripción clínica de 314 pacientes]#947547Repositorio de Universidad Autónoma de Chile.
• NYSCF Scientific Discovery Biobank#871873ClinicalTrials.gov
• Remyelination and neuroprotection translational trials: Lessons from optic neuritis#11657HAL (France)
• A pilot randomized controlled trial of neuromodulation-augmented balance training in people with multiple sclerosis: STIM-Balance Protocol.#28205NCBI PubMed Central
• Delayed Transcallosal Conduction to the Lesioned Sensorimotor Cortex in Multiple Sclerosis: A combined TMS 7T-MRI Study#68026bioRxiv / medRxiv
• Dyadic coping and multiple sclerosis: A qualitative exploration of differences between couples high and low in relationship functioning.#154169NCBI PubMed Central
• Quality of life domains revised by people with multiple sclerosis and healthcare professionals for adaptive measure development.#275277NCBI PubMed Central
• Disease Delineation for Multiple Sclerosis, Friedreich Ataxia, and Healthy Controls Using Supervised Machine Learning on Speech Acoustics#277490Repositorio USS
• Exploratory crossover field study indicates efficacy and feasibility of light therapy glasses to mitigate fatigue in multiple sclerosis.#312396NCBI PubMed Central
• Impact of Geographic and Person-Centered Barriers on Clinical Outcomes of Latino Patients With Multiple Sclerosis and Related Disorders#329337bioRxiv / medRxiv
• The Big Picture: 26 Years of Longitudinal Findings About Health Promotion and Quality of Life in Multiple Sclerosis.#409147NCBI PubMed Central
• The Role of Network Connectivity and Transcriptomic Vulnerability in Shaping Grey Matter Atrophy in Multiple Sclerosis#424598Europe PMC
• Delayed Transcallosal Conduction to the Lesioned Sensorimotor Cortex in Multiple Sclerosis: A combined TMS 7T-MRI Study#424640Europe PMC
• A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course#682995ClinicalTrials.gov
• Reliability, Validity and Clinical Utility of a Robotic Assessment for Proprioception#807997ClinicalTrials.gov
• Reliability and Validity Studies of Turkish Version of Manual Ability Measure-36#813704ClinicalTrials.gov
• Glucose Consumption in MS Using [F-18]FDG-PET#826559ClinicalTrials.gov
• The Effect of Hope Placement Program on Dıagnosed Wıth MS#832623ClinicalTrials.gov
• Walking Fatigability,Saptiotemporal Gait Parameters and Falling in MS Patients#841462ClinicalTrials.gov
• A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod#876171ClinicalTrials.gov
• Cognitive Dysfunction in MS: Using Altered Brain Oscillation to Link Molecular Mechanisms With Clinical Outcomes#876373ClinicalTrials.gov
• Pilot Investigation to Evaluate FlowOx2.0™ for Experimental Treatment of Spasticity#914865ClinicalTrials.gov